Skip to main content
. 2015 Sep 8;6(31):31493–31507. doi: 10.18632/oncotarget.5154

Figure 5. WNT7A is partially methylated in NPC clinical samples.

Figure 5

A. Schematic representation of WNT7A gene and the location of a CpG-rich region in its promoter. B. Eighty-four CpG sites in WNT7A promoter were analyzed by sequencing the clones derived from bisulfite converted DNA. Five to ten clones were sequenced for each sample. Open and filled circles represented unmethylated and methylated CpG sites, respectively. Circles are filled according to the percentage of clones with methylation of the CpG sites.